- AP214, a new ?MSH analogue, possesses anti-inflammatory activities
Montero Melendez Trinidad, Patel Hetal B, Seed Michael, Jonassen Thomas, Perretti Mauro
- A pharmacological characterisation of the thermostabilized turkey ?-adrenoceptor (t?trunc-M23)
baker jillian, tate christopher
- A Pharmacological investigation of the scorpion venom effect on the cardio-hepatic tissues: Correlation with inflammatory response
Adi Bessalem S, Laraba Djebari F
- A Pharmacological Profile of Receptor Tyrosine Kinase Inhibitors on VEGFR2-Stimulated NFAT Signalling in HEK-293 Cells.
JJ Carter, AJ Wheal, SJ Hill, J Woolard
- A Phase I, open label, ascending dose study of the safety, tolerability, pharmacokinetics and pharmacodynamics of the endothelin B agonist, SPI-1620, in patients with recurrent or progressive carcinoma
Tolcher A, Gari V, Reddy G, Lenaz L, Tidmarsh G, Gulati A
- A phase i study to determine the pharmacokinetic profile, safety and tolerability of sildenafil (REVATIO©) in cardiac surgery: the REVAKI-1 study.
A Ring, T Morris, M Wozniak, N Sullo, W Dott, V Verheyden, T Kumar, N Brunskill, R Vaja, G Murphy
- A Pilot Study Evaluating The Impact Of Community Pharmacist-led Interventions To Optimize Antihypertensive Medicines Adherence
A Amirthalingam, J Marriott
- A pilot study on measuring the activity level of fatty acid amide hydrolase (FAAH) in human blood
N. A. Anajirih, S. P. Alexander, S. E. O?Sullivan. life scinces, Nottingham university, Nottingham, United Kingdom
- A PK model to predict the impact of antibody enhancement technologies
Austin D, Berges A, Chen C
- A PK/PD Study Of A Selective A2a Agonist, (GW328267X) A Potential IV Therapeutic For Acute Lung Injury: No Tachyphylaxis To The Heart Rate Effect
A Allen, A Koch, N Garman, A Cahn, OE Dewitt, CN Rambaran
